Drug Shortage Report for NAPROSYN
Report ID | 204887 |
Drug Identification Number | 02162423 |
Brand name | NAPROSYN |
Common or Proper name | Naproxen sodium tablets USP |
Company Name | ATNAHS PHARMA UK LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | NAPROXEN |
Strength(s) | 500MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL ORAL |
Packaging size | 100s |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-09-21 |
Estimated end date | 2024-05-10 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-01 |
Company comments | Manufacturing delays |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | SOVEREIGN HOUSE, MILES GRAY ROAD BASILDON, ESSEX GREAT BRITAIN SS14 3FR |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2024-03-01 | French | Compare |
v11 | 2024-03-01 | English | Compare |
v10 | 2023-11-24 | French | Compare |
v9 | 2023-11-24 | English | Compare |
v8 | 2023-11-13 | French | Compare |
v7 | 2023-11-13 | English | Compare |
v6 | 2023-09-22 | English | Compare |
v5 | 2023-09-21 | French | Compare |
v4 | 2023-09-21 | English | Compare |
v3 | 2023-09-21 | English | Compare |
v2 | 2023-09-21 | French | Compare |
v1 | 2023-09-21 | English | Compare |
Showing 1 to 12 of 12